GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a remarkable shift in how we treat type 2 diabetes . These injectable drugs work by imitating the body’s natural GLP-1 substance , which https://single-bookmark.com/story21710712/glp-1-a-revolutionary-breakthrough-in-blood-sugar-treatment